PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
American Oncology Network Inc (AONCW)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

Sector

Healthcare

IPO Date

May 13, 2021

Highlights

Total Revenue (TTM)

$1.27B

Gross Profit (TTM)

$75.32M

Year Range

$0.00 - $0.50

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in American Oncology Network Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%SeptemberOctoberNovemberDecember2025February
53.33%
7.66%
AONCW (American Oncology Network Inc)
Benchmark (^GSPC)

Returns By Period

American Oncology Network Inc had a return of -8.00% year-to-date (YTD) and -48.60% in the last 12 months.


AONCW

YTD

-8.00%

1M

-0.00%

6M

53.33%

1Y

-48.60%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

3.96%

1M

1.97%

6M

9.03%

1Y

22.16%

5Y*

12.60%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of AONCW, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-8.00%-8.00%
20242.17%110.64%-31.29%-30.90%-44.68%-76.92%300.00%115.67%-46.02%31.35%52.59%-10.71%8.70%
2023-45.20%5.88%46.54%-10.16%-23.61%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for American Oncology Network Inc (AONCW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
No data
AONCW
^GSPC

There is not enough data available to calculate the Sharpe ratio for American Oncology Network Inc. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Chart placeholderNot enough data

Dividends

Dividend History


American Oncology Network Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-53.77%
-1.32%
AONCW (American Oncology Network Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the American Oncology Network Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the American Oncology Network Inc was 99.80%, occurring on Jun 11, 2024. The portfolio has not yet recovered.

The current American Oncology Network Inc drawdown is 53.77%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.8%Feb 23, 202463Jun 11, 2024
-68.09%Sep 21, 202328Nov 2, 202366Feb 21, 202494
-2.03%Sep 19, 20231Sep 19, 20231Sep 20, 20232

Volatility

Volatility Chart

The current American Oncology Network Inc volatility is 42.49%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%100.00%200.00%300.00%400.00%500.00%600.00%700.00%SeptemberOctoberNovemberDecember2025February
42.49%
4.08%
AONCW (American Oncology Network Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of American Oncology Network Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for American Oncology Network Inc.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab